Cite
MLA Citation
Asim Amin et al.. “Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results.” Journal for immunotherapy of cancer, vol. 3, no. 1, 2015, pp. 1–13. http://access.bl.uk/ark:/81055/vdc_100080855450.0x00003f